These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18225746)

  • 1. Antithrombotic activity of heparin-ATP complex.
    Obergan TY; Lyapina LA; Pastorova VE
    Bull Exp Biol Med; 2007 Mar; 143(3):299-301. PubMed ID: 18225746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of hemostatic properties of the complex and mixture of high molecular weight heparin and adenosine triphosphate].
    Liapina LA; Pastorova VE; Obergan TIu
    Izv Akad Nauk Ser Biol; 2007; (5):626-8. PubMed ID: 18038630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulant, fibrinolytic and antithrombotic effects of the heparin-insulin complex].
    Liapina LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2002; (6):710-3. PubMed ID: 12561334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant activity and platelet aggregation in blood plasma from rats after intranasal administration of adenosine triphosphate and its complex with heparin.
    Pastorova WE; Lyapina LA; Obergan TY; Shubina TA
    Bull Exp Biol Med; 2008 Sep; 146(3):273-5. PubMed ID: 19240836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant effects of a complex of high molecular weight heparin and arginine.
    Lyapina LA; Obergan TY; Pastorova VE
    Bull Exp Biol Med; 2009 Mar; 147(3):328-30. PubMed ID: 19529854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complex compound of heparin and glutamic acid: synthesis and effect on hemostasis parameters in vitro and in vivo].
    Liapina LA; Ziadetdinova GA
    Izv Akad Nauk Ser Biol; 2001; (1):82-6. PubMed ID: 11236584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidiabetic properties of high molecular weight heparin-adenosine triphosphate complex].
    Ul'ianov AM; Liapin LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2006; (1):77-80. PubMed ID: 16521542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
    Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
    J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemostaseological description of the heparin-adenosine triphosphate (ATP) complex].
    Liapina LA; Pastorova VE; Nikolaeva LS
    Izv Akad Nauk Ser Biol; 2005; (2):221-5. PubMed ID: 16004285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of chronic intramuscular administration of low molecular weight heparin-collagen complex on hemostatic indices and development of alloxan-induced diabetes].
    Liapina LA; Ul'ianov AM; Pastorova VE; Obergan TIu
    Izv Akad Nauk Ser Biol; 2006; (3):381-4. PubMed ID: 16771153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood interaction with a Bioline heparin coated HIA-VAD: a study on calves.
    van der Kamp KW; Magielse CP; Elstrodt JM; van der Meer J; van Oeveren W; Rakhorst G
    Int J Artif Organs; 1997 Jan; 20(1):43-50. PubMed ID: 9062831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of low doses of a heparin-urea complex on the aggregation of thrombocytes and the fibrinolytic activity of blood in intravenous infusion and in in vitro experiments].
    Kudriashov BA; Patorova VE; Liapina LA
    Farmakol Toksikol; 1975; 38(4):441-4. PubMed ID: 1213132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic and platelet activating effects of heparin in prevention of microarterial thrombosis.
    Arnljots B; Dougan P; Bergqvist D
    Plast Reconstr Surg; 1997 Apr; 99(4):1122-8. PubMed ID: 9091912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
    Maurin N
    Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
    Kudriashov BA; Pastorova VE; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of adhesion of the abdominal organs].
    Daurova TT; Andreev SD
    Khirurgiia (Mosk); 1974 Mar; 50(3):102-6. PubMed ID: 4839312
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR; Nazareth RA; Mourão PA
    Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis.
    Vairel EG; Bouty-Boye H; Toulemonde F; Doutremepuich C; Marsh NA; Gaffney PJ
    Thromb Res; 1983 May; 30(3):219-24. PubMed ID: 6683432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.